Unlocked Access
FULL SUPPLEMENT: Nordic European Cutaneous Oncodermatology Management (Necom) 7: Real-World Cases Applying Recommendations for the Prevention and Treatment of Skin Reactions Related to Cancer Therapies Using Skin-Protective Measures
December 2025 | Volume 24 | Issue 12 | Department | 508410s1 | Copyright © December 2025
The current risk of getting cancer before age 80 in Nordic countries is estimated at 42.7% in males and 36.2% in females. Based on the collaborative Nordic cancer registry (NORDCAN), breast, lung, and...
Read MoreFDA Boxed Warnings: Should Package Inserts Include Levels of Evidence?
December 2025 | Volume 24 | Issue 12 | Features | e67 | Copyright © December 2025
Many medications commonly used in dermatology come with package inserts that contain boxed warnings that are frequently not evidence-based. Boxed warnings are the most serious warnings that the U...
Read MoreINDIVIDUAL ARTICLE: NECOM 7: Real-World Cases on Preventive and Treatment Using Skin Care for Cancer Treatment-Related Skin Reactions
December 2025 | Volume 24 | Issue 12 | Supplement Individual Articles | 50842s3 | Copyright © December 2025
As cancer prevalence continues to increase in Nordic countries, the amount of dermatological adverse events, termed cutaneous adverse events (cAEs), will also increase. The Nordic European Cutane...
Read MoreClinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation
December 2025 | Volume 24 | Issue 12 | Original Article | 1195 | Copyright © December 2025
Background: Cutaneous hyperpigmentation, which includes melasma, post-inflammatory hyperpigmentation, and solar lentigines, significantly impacts patients' quality of life. The o...
Read MoreThe Overlooked Burden: Psychodermatologic Needs of Hispanic and Latinx Communities in the United States
December 2025 | Volume 24 | Issue 12 | Features | e70 | Copyright © December 2025
Pyoderma Gangrenosum Following Total Colectomy for Ulcerative Colitis
December 2025 | Volume 24 | Issue 12 | Case Reports | 1254 | Copyright © December 2025
INDIVIDUAL ARTICLE: The Dark Side of Oral Antibiotics: Adverse Events of Consideration in Dermatology
November 2025 | Volume 24 | Issue 11 | Supplement Individual Articles | s4 | Copyright © November 2025
Antibiotics remain a cornerstone in the management of dermatologic conditions such as acne and hidradenitis suppurativa, underscoring the need for responsible antibiotic stewardship. This article...
Read MoreINDIVIDUAL ARTICLE: Vehicle Matters: Triple Combo for Acne Vulgaris
November 2025 | Volume 24 | Issue 11 | Supplement Individual Articles | s1 | Copyright © November 2025
Although data suggest that antibiotic use by dermatologists is decreasing, our specialty still has the highest rates of oral antibiotic prescribing across all fields of medicine......
Read MoreNECASA II: A Practical Algorithm Integrating Skincare in the Management of Adult Female Acne in the Nordic European Countries
November 2025 | Volume 24 | Issue 11 | Original Article | 1094 | Copyright © November 2025
Background: Adult female acne presents challenges, including increased prevalence, distinct clinical manifestations, heightened skin sensitivity, treatment-related intolerance, a...
Read MoreMolecular Insights: Immune and Barrier Dysregulation in Seborrheic Dermatitis
November 2025 | Volume 24 | Issue 11 | Features | 1144 | Copyright © November 2025
INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema
October 2025 | Volume 24 | Issue 10 | Supplement Individual Articles | 025412 | Copyright © October 2025
Chronic hand eczema (CHE) affects up to 10% of the general population and is associated with significant physical discomfort, impaired hand function, and reduced quality of life, yet effective lo...
Read MoreINDIVIDUAL ARTICLE: VEHICLES MATTER
October 2025 | Volume 24 | Issue 10 | Supplement Individual Articles | 025411 | Copyright © October 2025
Management of CHE can be complicated by numerous factors, including the possibility that contact irritants or allergens–including occupational exposures–contribute to the condition. Additi...
Read MoreFULL SUPPLEMENT: Time To Get Hands On: Delgocitinib's Promise For Chronic Hand Eczema
October 2025 | Volume 24 | Issue 10 | Department | 025410 | Copyright © October 2025
Despite its prevalence and impact on patients’ lives, treatment options are limited, with many patients showing inadequate response or intolerance to topical corticosteroids and systemic immunos...
Read MoreSAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare
October 2025 | Volume 24 | Issue 10 | Original Article | 1012 | Copyright © October 2025
Background: Atopic dermatitis (AD) is a common heterogeneous disorder that typically starts in infancy and early childhood, is associated with the development of comorbidities, a...
Read MoreThe Emerging Role of Oncodermatology in a Hemato-Oncology Unit in a Tertiary Hospital
October 2025 | Volume 24 | Issue 10 | Original Article | 1018 | Copyright © October 2025
Background: Our dermatology department consistently receives the largest proportion of internal on-call referrals from the Hematology-Oncology Department. Individuals with hemato...
Read MoreExamining an Antioxidant Biostimulating Treatment for Dark, Postinflammatory Hyperpigmentation-Prone Skin
October 2025 | Volume 24 | Issue 10 | Features | 1046 | Copyright © October 2025
Skin rejuvenation treatments, including chemical peels and biostimulatory therapies, aim to improve facial aging concerns. However, these treatments have limitations, including efficacy, safety, ...
Read MoreThe Role of Simultaneous Janus Kinase Inhibitor and Biologic Therapy Use for Refractory Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Case Reports | 1043 | Copyright © October 2025
Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case Report
October 2025 | Volume 24 | Issue 10 | Case Reports | 1041 | Copyright © October 2025
The Dermatologic Hazards of Nail Product Usage
October 2025 | Volume 24 | Issue 10 | Features | 1051 | Copyright © October 2025
The major dermatologic adverse effect of nail polish that has been reported is an allergic contact dermatitis. This can within the ungual and periungual region, but it can also be diffuse and spr...
Read MoreTrichoscopic Images Observed in Popular Head Spa Salons: Are We Headed in the Right Direction?
September 2025 | Volume 24 | Issue 9 | Features | 942 | Copyright © September 2025
© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
